Your browser doesn't support javascript.
loading
Baseline neuropsychological profiles in prion disease predict survival time.
Sundaram, Saranya E; Staffaroni, Adam M; Walker, Nicole C; Casaletto, Kaitlin B; Casey, Megan; Golubjatnikov, Aili; Metcalf, Stacy; O'Leary, Kelly; Wong, Katherine; Benisano, Kendra; Forner, Sven; Gonzalez Catalan, Marta; Allen, Isabel E; Rosen, Howard J; Kramer, Joel H; Geschwind, Michael D.
Afiliación
  • Sundaram SE; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Staffaroni AM; Department of Psychology, Palo Alto University, Palo Alto, California.
  • Walker NC; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Casaletto KB; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Casey M; Department of Psychology, California School of Professional Psychology, Alliant International University, San Francisco, California.
  • Golubjatnikov A; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Metcalf S; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • O'Leary K; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Wong K; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Benisano K; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Forner S; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Gonzalez Catalan M; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Allen IE; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Rosen HJ; Department of Neurology, Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California.
  • Kramer JH; Department of Psychology, Palo Alto University, Palo Alto, California.
  • Geschwind MD; Department of Epidemiology and Biostatistics, University of California, San Francisco, California.
Ann Clin Transl Neurol ; 7(9): 1535-1545, 2020 09.
Article en En | MEDLINE | ID: mdl-33314770
OBJECTIVE: Few studies have captured the neuropsychological profile of sporadic Creutzfeldt-Jakob disease (sCJD) with neuropsychological testing, and little is known about cognitive predictors of survival. We characterized baseline neuropsychological performance in sCJD and investigated associations with survival. METHODS: sCJD participants who completed the MMSE (n = 118), 61 sCJD of whom also completed a neuropsychological battery at baseline, and 135 age-matched healthy controls, were included. Composite scores of global cognition, memory, executive functions, visuospatial, and language were derived. Cox proportional hazard models estimated survival time, controlling for age and education. Additional models adjusted for Barthel Index and PRNP codon 129 polymorphism. RESULTS: sCJD participants performed significantly worse than controls on all cognitive tasks and composites with most showing very large effect sizes. The three tests showing the largest group differences were delayed verbal recall (Hedges'g = 4.08, P < 0.0001), Stroop Inhibition (Hedges'g = 3.14, P < 0.0001), and Modified Trails (Hedges'g = 2.94, P < 0.0001). Memory (95%) and executive functioning (87%) composites were most commonly impaired. Poorer global (HR = 0.65, P < 0.0001), visuospatial (HR = 0.82, P < 0.0001), and memory (HR = 0.82, P = 0.01) composites predicted shorter survival. Visuospatial cognition remained a significant predictor even after adjusting for all other cognitive composites; each standard deviation decrease in visuospatial cognition was associated with an 18% higher chance of death (HR = 0.82, P < 0.003). Global (HR = 0.68, P = 0.03) and visuospatial (HR = 0.82, P = 0.001) composites remained significant predictors after controlling for Barthel Index and codon 129. INTERPRETATION: sCJD participants exhibit a broad range of cognitive impairments, with memory and executive functioning deficits in the vast majority. Neuropsychological assessment, particularly of visuospatial abilities, informs prognostication in sCJD.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Creutzfeldt-Jakob / Función Ejecutiva / Disfunción Cognitiva / Trastornos de la Memoria Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Clin Transl Neurol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Creutzfeldt-Jakob / Función Ejecutiva / Disfunción Cognitiva / Trastornos de la Memoria Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Clin Transl Neurol Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos